C2 monitoring: A reliable tool in pediatric renal transplant recipients [9]

Transplantation

Volumn 76, Issue 2, 2003, Pages 444-445

  Strologo, L Dello ^a   Pontesilli, C ^a   Rizzoni, G ^a   Tozzi, A E ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; AREA UNDER THE CURVE; CHILD; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG METABOLISM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; PATIENT MONITORING; PEDIATRICS; PRIORITY JOURNAL; RELIABILITY;

CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; REPRODUCIBILITY OF RESULTS;

EID: 0043269177     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000074312.93200.7A     Document Type: Letter

References (6)

1. Amante AJ, Kahan BD. Abbreviated area-under-the-curve strategy for monitoring cyclosporine microemulsion therapy in immediate posttransplant period. Clin Chem 1996; 42: 1294-1296.
2. Dello Strologo L, Campagnano P, Federici G, et al. Cyclosporine A monitoring in children: abbreviated area under curve formulas and C2 level. Pediatr Nephrol 1999; 13: 95-97.
3. Cantarovich M, Besner JG, Barkun JS, et al. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy. Clin Transplant 1998; 12: 243-249.
4. Absorption profiling of cyclosporine microemulsion (Neoral) during the first 2 weeks after renal transplantation. Transplantation 2001:72: 1024-1032.
5. Grant D, Kneteman N, Tchervenkov J, et al. Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of Neoral and Sandimmune for liver transplantation (NOF-8). Transplantation 1999; 67: 1133-1137.
6. Hoyer PF. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group. Pediatr Transplant 1998; 2: 35-39.